Eléonore JOUANNY
CMC Lead at Corteria Pharmaceuticals- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Corteria Pharmaceuticals
-
France
-
Biotechnology Research
-
1 - 100 Employee
-
CMC Lead
-
Jan 2023 - Present
∙ Lead from Drug Substance (DS) synthesis to Investigational Medicinal Product (IMP) Release for Clinical Studies: DS manufacturing and control, Drug Product development, IMP production, IMPD writing, clinical study, budget, timelines. ∙ Peptides, Antibody, Injectables ∙ CMC strategy, Supplier selection ∙ Board reporting, Due Diligence Response to Questions ∙ QA system implementation ∙ Lead from Drug Substance (DS) synthesis to Investigational Medicinal Product (IMP) Release for Clinical Studies: DS manufacturing and control, Drug Product development, IMP production, IMPD writing, clinical study, budget, timelines. ∙ Peptides, Antibody, Injectables ∙ CMC strategy, Supplier selection ∙ Board reporting, Due Diligence Response to Questions ∙ QA system implementation
-
-
-
SUBSTIPHARM
-
France
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Pharmaceutical Development PM
-
Nov 2016 - Dec 2022
• Feasability study: development strategy definition (including QbD), offers review and negotiations, CDMO/CMO/supplier selection, R&D agreement • Project management from lab to industrial scale batches: formulation & production documentation validation, material supply, Bio- or in-vitro equivalence studies coordination, budget, timelines, KPI definition, MA file review, deficiency letter answer writting • Transversal team coordination between leads and experts: formulation, analytical, clinical, QA, CMC, CDMO, CMO, CRO, suppliers… • Interns and newly hired people management Show less
-
-
-
BIOGARAN
-
France
-
Pharmaceutical Manufacturing
-
200 - 300 Employee
-
Technological Transfer and Industrialization Project Manager
-
Apr 2012 - Nov 2016
- Management of several projects : dealing with all technical aspects of developpement, industrilization, and launch of new products, transfer of production, addition of new API sources. - Approval of all related documents (BMI, BPI, validation protocol and reports). - Writting of 3.2.P.3. part of the MA file. - Quotation requests for the transfer of production and offers analysis. - SOP writting. - Management of several projects : dealing with all technical aspects of developpement, industrilization, and launch of new products, transfer of production, addition of new API sources. - Approval of all related documents (BMI, BPI, validation protocol and reports). - Writting of 3.2.P.3. part of the MA file. - Quotation requests for the transfer of production and offers analysis. - SOP writting.
-
-
-
-
PhD - Pharmacotechny and Biopharmacy
-
Oct 2007 - Feb 2011
Chargée de mettre au point des formules d'émulsions naturelles H/E stabilisées par des protéines et des polysaccharides en vue d'applications pharmaceutiques ou cosmétiques. Caractérisations physico-chimiques des émulsions, synthèse et analyse critique des résultats obtenus. Présentations et publications de ceux-ci au sein d'articles scientifiques et/ou lors de congrès internationaux. Egalement en charge de stagiaires tout au long de mon projet. Chargée de mettre au point des formules d'émulsions naturelles H/E stabilisées par des protéines et des polysaccharides en vue d'applications pharmaceutiques ou cosmétiques. Caractérisations physico-chimiques des émulsions, synthèse et analyse critique des résultats obtenus. Présentations et publications de ceux-ci au sein d'articles scientifiques et/ou lors de congrès internationaux. Egalement en charge de stagiaires tout au long de mon projet.
-
-
-
-
Formulation Development Intern
-
Jun 2006 - Sep 2006
-
-
Education
-
Université Paris Sud (Paris XI)
Doctorat, Pharmacotechnie et Biopharmacie -
Université Paris Sud (Paris XI)
Master, Pharmacotechnie et Biopharmacie -
Université Paris Sud (Paris XI)
Docteur en Pharmacie